Integrated Core Strategies (US) LLC 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-09 4:23 pm Sale | 2025-12-31 | 13G | VANDA PHARMACEUTICALS INC VNDA | Integrated Core Strategies (US) LLC | 1,679,013 2.800% | -1,441,326 (-46.19%) | Filing |
| 2025-07-01 4:31 pm Purchase | 2025-06-27 | 13G | VANDA PHARMACEUTICALS INC VNDA | Integrated Core Strategies (US) LLC | 3,120,339 5.300% | 3,120,339 (New Position) | Filing |